Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: stockman_scott who wrote (7192)	4/17/2002 10:36:39 AM
From: im a survivor	Respond to of 13815

Scott....you or anybody else messing with HQNT......quite a recent run from .20 to .67 wondering if she continues to rise, or drops back down.....dd looked very good.....insider buying....I like insider buying !! As for me and my wife being in "great shape".....Most definatly, my wife is fit as a fiddle....however I have a few health concerns...but I still am into my extreme sports whenever I can, and my health/body/work, allows.....

To: stockman_scott who wrote (7192)	4/17/2002 10:46:14 AM
From: im a survivor	Respond to of 13815

H-Quotient, Inc., Announces More Than 1 Million Shares Purchased by Dr. Laipply VIENNA, Va., April 8 /PRNewswire-FirstCall/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT) announced that Dr. Thomas C. Laipply, MD, FCAP, FIAP, Director of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics, has purchased more than 1 million shares of H-Quotient, Inc., common stock. None of these purchases were made during the blackout period while LabQuotient, the company's innovative new relational database for improving and monitoring medical test ordering, was being discussed and contracted with him. Dr. Laipply said, "I began to accelerate my purchases of H-Quotient stock this year because of the impressive performance by the company's CEO, Mr. Cohn, and the strength of management represented by him, Dr. Copley and more recently by Mr. Burden. Further, I understand the potential of the company's products and the opportunities created for additional products. The management, the science and the finances combined to create a compelling case, and I intend to continue adding to my position." This announcement may contain, in addition to historical information, certain forward-looking statements that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. For more information visit the H-Quotient web site at hquotient.com . MAKE YOUR OPINION COUNT - Click Here tbutton.prnewswire.com SOURCE H-Quotient, Inc. CO: H-Quotient, Inc.; Quest Diagnostics ST: Virginia IN: FIN MTC OTC SU: 04/08/2002 07:48 EDT prnewswire.com